跳转至内容
Merck

88886

Sigma-Aldrich

9-(Bromomethyl)acridine

BioReagent, suitable for fluorescence, ≥97.0% (HPLC)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C14H10BrN
CAS号:
分子量:
272.14
Beilstein:
159526
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.32

產品線

BioReagent

化驗

≥97.0% (HPLC)

形狀

powder

mp

160-165 °C

螢光

λex 335 nm; λem 469 nm in 0.1 M phosphate pH 7.0 (after derivatization with glutathione)

適合性

suitable for fluorescence

SMILES 字串

BrCc1c2ccccc2nc3ccccc13

InChI

1S/C14H10BrN/c15-9-12-10-5-1-3-7-13(10)16-14-8-4-2-6-11(12)14/h1-8H,9H2

InChI 密鑰

MZFYKBHQWLWIBI-UHFFFAOYSA-N

分析報告

In addition to the emission maximum at 447 nm, there are lower maxima at 468 and 413 nm.

其他說明

HPLC derivatizing agent for fluorescent labeling of carboxylic acids, e.g. fatty acids[1][2][3]

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

K. Akasaka et al.
Analytical Letters, 20, 1581-1581 (1987)
Wakako Tsuzuki et al.
The Analyst, 127(5), 669-673 (2002-06-26)
For the purpose of deducing the digestive behavior of dietary fat in the digestive organs, a fluorimetric method for the measurement of hydrolysis by porcine pancreatic lipase was performed using intermediate- and long- acyl chain glycerides as substrates. Insoluble glycerides
F A van der Horst et al.
Journal of chromatography, 500, 443-452 (1990-02-02)
The on-line use of micellar phase-transfer catalysis is described for the automated reversed-phase high-performance liquid chromatographic (RP-HPLC) determination of free fatty acids in plasma; minimum manual sample handling is involved. After diluting plasma ten-fold with the aqueous micellar system, which
Yi-Shan Li et al.
Talanta, 218, 121143-121143 (2020-08-17)
Dipeptidyl peptidase 4 (DPP-4) inhibitors are incretin-based medications used as oral antidiabetic agents for the treatment of type 2 diabetes. However, DPP-4 inhibitors produce side effects like acute pancreatitis, upper respiratory tract infection, nasopharyngitis, urinary tract infection, serious allergies, cardiovascular

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门